INSMED INC's ticker is INSM and the CUSIP is 457669307. A total of 117 filers reported holding INSMED INC in Q2 2017. The put-call ratio across all filers is 3.75 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,787,500 | +46.6% | 150,000 | +25.0% | 0.07% | +16.4% |
| Q3 2022 | $2,584,000 | +44.3% | 119,972 | +60.0% | 0.06% | +3.4% |
| Q4 2019 | $1,791,000 | +1.5% | 75,000 | -25.0% | 0.06% | -15.7% |
| Q3 2019 | $1,764,000 | -31.1% | 100,000 | 0.0% | 0.07% | +16.7% |
| Q2 2019 | $2,560,000 | +64.0% | 100,000 | +100.0% | 0.06% | +100.0% |
| Q3 2017 | $1,561,000 | +263.9% | 50,000 | +100.0% | 0.03% | +130.8% |
| Q2 2017 | $429,000 | – | 25,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management IV, LLC | 1,799,225 | $40,519,000 | 16.80% |
| Foresite Capital Management II, LLC | 967,636 | $21,791,000 | 7.25% |
| Palo Alto Investors LP | 7,159,590 | $161,234,000 | 6.90% |
| Asymmetry Capital Management, L.P. | 162,185 | $3,652,000 | 4.57% |
| NEXTHERA CAPITAL LP | 918,523 | $20,685,000 | 3.41% |
| Redmile Group, LLC | 2,166,362 | $48,786,000 | 1.88% |
| Orbimed Advisors | 2,927,891 | $65,936,000 | 0.82% |
| Rock Springs Capital Management LP | 825,000 | $18,579,000 | 0.79% |
| Bellevue Group AG | 334,489 | $7,533,000 | 0.75% |
| EMERALD ADVISERS, LLC | 726,946 | $16,371,000 | 0.66% |